DOCSLIB.ORG

Contents of Volume 81, 2017

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

ii Contents of Volume 81, 2017 CONTENTS OF VOLUME 81, 2017 Message From the Editor-in-Chief 1. Circulation Journal Has Changed Its Style Toyoaki Murohara ········ 1 2. Editorial Statistics and Best Reviewers Award for 2016 Toyoaki Murohara ········ 127 3. Circulation Journal Awards for the Year 2016 Toyoaki Murohara ········ 273 4. Rapid Publication and Announcement of the 2017 JCS Meeting Activities Toyoaki Murohara ········ 615 5. Announcement of the 2017 JCS Meeting Activities (2) Toyoaki Murohara ········ 767 6. Message From the Editor-in-Chief Toyoaki Murohara ········ 1063 7. Message From the Editor-in-Chief Toyoaki Murohara ········ 1241 8. Message From the Editor-in-Chief Toyoaki Murohara ········ 1377 In Memoriam 1. Mitsuhiro Yokoyama, MD, PhD 1943–2016 Ken-ichi Hirata ········ 901 Reviews 1. Coronary Microvascular Dysfunction ― Epidemiology, Pathogenesis, Prognosis, Diagnosis, Risk Factors and Therapy ― Cheng Chen, Janet Wei, Ahmed AlBadri, Parham Zarrini, C. Noel Bairey Merz ········ 3 2. Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes Vassilios J. Bezzerides, Donghui Zhang, William T. Pu ········ 12 3. Reperfusion Damage ― A Story of Success, Failure, and Hope ― Roberto Ferrari, Cristina Balla, Michele Malagù, Gabriele Guardigli, Giampaolo Morciano, Matteo Bertini, Simone Biscaglia, Gianluca Campo ········ 131 4. Myocardial Regeneration for Humans ― Modifying Biology and Manipulating Evolution ― Kathleen M. Broughton, Mark A. Sussman ········ 142 5. Pathophysiology of Intermittent Claudication in Peripheral Artery Disease Naomi M. Hamburg, Mark A. Creager ········ 281 6. The Brugada Syndrome ― From Gene to Therapy ― Antonio Curcio, Giuseppe Santarpia, Ciro Indolfi ········ 290 7. Significance and Value of Endomyocardial Biopsy Based on Our Own Experience Hatsue Ishibashi-Ueda, Taka-aki Matsuyama, Keiko Ohta-Ogo, Yoshihiko Ikeda ········ 417 8. Critical Care Management Focused on Optimizing Brain Function After Cardiac Arrest Ryuta Nakashima, Toru Hifumi, Kenya Kawakita, Tomoya Okazaki, Satoshi Egawa, Akihiko Inoue, Ryutaro Seo, Nobuhiro Inagaki, Yasuhiro Kuroda ········ 427 9. Heart Transplantation in Asia Hae-Young Lee, Byung-Hee Oh ········ 617 10. Sterile Inflammation and Degradation Systems in Heart Failure Kazuhiko Nishida, Kinya Otsu ········ 622 11. The Complex Genetic Basis of Congenital Heart Defects Ehiole Akhirome, Nephi A. Walton, Julie M. Nogee, Patrick Y. Jay ········ 629 12. Dipeptidyl Peptidase-IV Inhibition for the Treatment of Cardiovascular Disease ― Recent Insights Focusing on Angiogenesis and Neovascularization ― Yanna Lei, Lina Hu, Guang Yang, Limei Piao, Minggen Jin, Xianwu Cheng ········ 770 13. Sleep-Disordered Breathing in Heart Failure ― A Therapeutic Dilemma ― Nobuhiko Haruki, John S. Floras ········ 903 Circulation Journal Vol.81, December 2017 Contents of Volume 81, 2017 iii 14. Atrial Natriuretic Peptide ― Old But New Therapeutic in Cardiovascular Diseases ― Tomoko Ichiki, John C. Burnett Jr ········ 913 15. Role of Adipokines in Cardiovascular Disease Wayne Bond Lau, Koji Ohashi, Yajing Wang, Hayato Ogawa, Toyoaki Murohara, Xin-Liang Ma, Noriyuki Ouchi ········ 920 16. Recent Progress Using Pluripotent Stem Cells for Cardiac Regenerative Therapy Hajime Ichimura, Yuji Shiba ········ 929 17. Bioresorbable Vascular Scaffolds ― Are We Facing a Time of Crisis or One of Breakthrough? ― Jeehoon Kang, Jung-Kyu Han, Han-Mo Yang, Kyung Woo Park, Hyun-Jae Kang, Bon-Kwon Koo, Hyo-Soo Kim ········ 1065 18. Prognostic Value of Chronic Kidney Disease Measures in Patients With Cardiac Disease Yejin Mok, Shoshana H. Ballew, Kunihiro Matsushita ········ 1075 19. Noninvasive Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography ― Is This Just Another New Diagnostic Test or the Long-Awaited Game Changer? ― Hiromasa Otake, Charles A. Taylor, Hitoshi Matsuo, Nobuhiro Tanaka, Takashi Akasaka ········ 1085 20. Investigations of Carotid Stenosis to Identify Vulnerable Atherosclerotic Plaque and Determine Individual Stroke Risk Madieke I. Liem, Fiona Kennedy, Leo H. Bonati, Aad van der Lugt, Bram F. Coolen, Aart J. Nederveen, Hans R. Jager, Martin M. Brown, Paul J. Nederkoorn ········ 1246 21. Clinical Implications of Electrocardiograms for Patients With Type A Acute Aortic Dissection Masami Kosuge, Kazuo Kimura, Keiji Uchida, Munetaka Masuda, Kouichi Tamura ········ 1254 22. ANGPTL2 ― A New Causal Player in Accelerating Heart Disease Development in the Aging ― Yuichi Oike, Zhe Tian, Keishi Miyata, Jun Morinaga, Motoyoshi Endo, Tsuyoshi Kadomatsu ········ 1379 23. Development of Novel Therapies for Cardiovascular Diseases by Clinical Application of Basic Research Kimio Satoh ········ 1557 24. Prothrombin Complex Concentrate for Vitamin K Antagonist-Associated Intracranial Hemorrhage ― Global Evidence and the Japanese Perspective ― Masahiro Yasaka, Andres Brainsky, Kazunori Toyoda ········ 1564 25. Metabolic Considerations in Atrial Fibrillation ― Mechanistic Insights and Therapeutic Opportunities ― Masahide Harada, Jonathan Melka, Yoshihiro Sobue, Stanley Nattel ········ 1749 Report of Heart Transplantation in Japan 1. Registry Report on Heart Transplantation in Japan (June 2016) Norihide Fukushima, Minoru Ono, Yoshikatsu Saiki, Yoshiki Sawa, Shinichi Nunoda, Mitsuaki Isobe ········ 298 Congress Reports 2016 AHA Report 1. Report of the American Heart Association (AHA) Scientific Sessions 2016, New Orleans Makoto Amaki, Nao Konagai, Masashi Fujino, Shouji Kawakami, Kazuhiro Nakao, Takuya Hasegawa, Yasuo Sugano, Yoshio Tahara, Satoshi Yasuda ········ 22 2017 ACC Report 2. Report of the Annual Scientific Sessions of the American College of Cardiology (ACC), Washington DC Takafumi Hiro ········ 777 2017 JCS Report 3. Overview of the 81st Annual Scientific Meeting of the Japanese Circulation Society ― Cardiovascular Medicine for the Next Generation ― Noboru Fujino, Tsuyoshi Yoshimuta, Fukiko Ichida, Koichiro Kinugawa, Kazuo Usuda, Michihiko Kitayama, Hidekazu Ino, Masa-aki Kawashiri, Hiroshi Tada, Sumio Mizuno, Kenshi Hayashi, Hirofumi Takemura, Masakazu Yamagishi on behalf of all the members of the Japanese Circulation Society in Hokuriku District ········ 1261 2017 ESC Report 4. European Society of Cardiology (ESC) Annual Congress Report From Barcelona 2017 Kimio Satoh, Jun Takahashi, Yasuharu Matsumoto, Shunsuke Tatebe, Tatsuo Aoki, Yoku Kikuchi, Kiyotaka Hao, Kazuma Ohyama, Masamichi Nogi, Akira Suda, Shintaro Kasahara, Koichi Sato, Sadamitsu Ichijo, Hiroaki Shimokawa ········ 1758 Editorials 1. Hospitalization Deteriorates Performance of Activities of Daily Living by Super-Elderly Patients With Heart Failure Hideo Izawa, Yuji Kohno, Wakaya Fujiwara, Mutsuharu Hayashi ········ 28 Circulation Journal Vol.81, December 2017 iv Contents of Volume 81, 2017 2. Genitourinary Hemorrhagic Complications and Malignancies in Patients Receiving Anticoagulation Therapy Eitaro Kodani ········ 149 3. Timing of Anticoagulant Therapy After Acute Ischemic Stroke Ryu Matsuo, Masahiro Kamouchi ········ 151 4. More Attention Should Be Paid to Abnormalities of Circadian Blood Pressure Rhythm in Heart Failure Patients Mamiko Kai, Hisashi Kai ········ 153 5. Asian Perspective of the EMPA-REG OUTCOME Study Yasuko K. Bando, Toyoaki Murohara ········ 155 6. Assessment of Atherosclerosis ― Vascular Imaging Tests and Vascular Function Tests ― Yukihito Higashi ········ 304 7. Optimal Anticoagulation for Patients With Atrial Fibrillation — Benefits for Reducing Stroke Severity — Masahiro Kamouchi ········ 306 8. Antithrombotic Regimens in Patients Undergoing Transcatheter Aortic Valve Implantation Noriaki Tabata, Kenichi Tsujita ········ 308 9. Rigid Left Ventricle With Attenuated Torsion as the Integrally Deteriorated Form of Dilated Cardiomyopathy Yoshihiro Seo, Tomoko Ishizu, Kazutaka Aonuma ········ 440 10. Improvement in Quality of Life in Chronic Thromboembolic Pulmonary Hypertension With Balloon Pulmonary Angioplasty Toru Satoh ········ 442 11. Renin-Angiotensin-Aldosterone System and Natriuretic Peptides as Possible Targets of Waon Therapy in Heart Failure Arata Fukushima, Shintaro Kinugawa ········ 635 12. Outstanding Effect of Physical Exercise on Endothelial Function Even in Children and Adolescents Kensuke Noma, Yasuki Kihara, Yukihito Higashi ········ 637 13. How Should We Treat School-Aged Children With Borderline QT Prolongation? Seiko Ohno ········ 640 14. Tolvaptan, Is It a Trump to Worsening Renal Function? Shin-ichi Momomura ········ 642 15. Gamma-Glutamyl Transferase as a Risk Biomarker of Cardiovascular Disease ― Does It Have Another Face? ― Yoshihiro Seo, Kazutaka Aonuma ········ 783 16. Getting Osteoporotic Fracture Risk Into Vascular Structure and Function ― Do You Know Your FRAX® Score? ― Toshihiro Tsuruda, Kazuo Kitamura ········ 786 17. Translational Study of Hydrogen Gas Inhalation as Adjuncts to Reperfusion Therapy for Acute Myocardial Infarction Hiroshi Asanuma, Masafumi Kitakaze ········ 936 18. Novel Strategies for the Management of Nocturnal Hypertension Masaaki Miyata, Mitsuru Ohishi ········ 938 19. QRS Score ― Possibilities and Limitations ― Jun Kishihara, Junya Ako ········ 1094 20. Association Between Bathing and Sudden Death Yoshio Tahara ········ 1096 21. Do We Expect Any Pleiotropic Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition for Reducing Cardiovascular Events Beyond Low-Density Lipoprotein Cholesterol Reduction? Hayato Tada, Masa-aki Kawashiri, Masakazu Yamagishi ········ 1098 22. Yummy Food Is
Recommended publications
  • Program 1..161

    Program 1..161

    The 93rd Annual Meeting of CSJ Program Chair: Ishitani, Osamu（15：30～16：20） Room S1 2S1- 06 Special Lecture Photocatalytic hydrogen evolution from water （Tokyo University of Science, Faculty of Science）Kudo, Akihiko（15:30～ 15:55） CO-LEARNING HOUSE I C102 2S1- 07 Special Lecture Development of visible light responsive semi- conductor photocatalysts（School of Engineering, The University of Tokyo） Domen, Kazunari（15:55～16:20） Frontiers of Artificial Photosynthesis JST- Chair: Inoue, Haruo（16：20～17：30） PRESTO Project "Chemical Conversion of 2S1- 08 Special Lecture How to make good use of near infrared light Light Energy" energy?（RIES, Hokkaido Univ.）Misawa, Hiroaki（16:20～16:45） 2S1- 09 Friday, March 22, AM Special Lecture Road Map of artificial photosynthesis to Future Industry（Mitsubishi Chemical Science and Technology Research Center （9：40 ～12：10） Inc.）Setoyama, Tohru（16:45～17:10） 1S1- 02# Watching Chemical Conversion of Light Energy with Picosecond 2S1- 10 Special Lecture Artificial Photosynthesis: Perspective from Time-resolved X-ray Structural Analysis（KEK）ADACHI, Shin-ichi（09:40 Science and Technology Policy and Scientists（School of Engineering, ～10:10） University of Tokyo）Hashimoto, Kazuhito（17:10～17:30） 1S1- 03# Development of Large Photofunctional Porphyrin Arrays（NAIST） ARATANI,Naoki（10:10～10:40） 1S1- 04# Development of energy conversion materials with hierarchical struc- ture using two-dimensional nanocrystals （Kyushu Univ.）IDA, Shintaro Room S2 （10:40～11:10） 1S1- 05# Development of highly-active oxygen evolving catalysts toward CO-LEARNING
  • Poster Reconstraction Using Cementless Acetabular Cup Are Satisfactory

    Poster Reconstraction Using Cementless Acetabular Cup Are Satisfactory

    Poster reconstraction using cementless acetabular cup are satisfactory. If P1-001 there is large bone defect, bone graft should be considered. Synovial cell proliferation and reparative regeneration in knee osteoarthritis Shuichi Karasaki P1-004 Research Laboratory of Nippon Well-Being Foundation, Aidu Chuo The difference of serum MMP-3 during operative procedure in Hospital, Aizuwakamatsu, Japan highly activated RA Naohiro Asada Knee joint aspirations of synovial fluids were obtained from OA Tsuruga Municipal Hospital outpatients for consecutive <18 years. The fluids contained fine pieces of synovial villi (SV), which were densely packed with grow- We have evaluated change of serum MMP-3 level between pre ing embryonic-like mesenchymal cells, in order to restore the miss- and post operative procedures including the synovectomy in patients ing parts of degenerated cartilage surface. In vitro properties of SV with highly activated RA. Five patients were female, and one was cells were examined within syringes (suspension) and flasks (adher- male. The average of age was 71 years old. Total joint replacement ence). Hyaluronan was produced during the mitosis period of was performed in 5 cases, arthroscopic synovectomy was performed growth cycle of SV cells and provided an environment conductive to in 4 cases, in all 6 patients. They had not been treated with Bio-thea- the growth and migration of mesenchymal cells in suspension cul- py before the surgery. The significant difference between before and ture. Released SV cells took on the characteristic of growing macro- after surgery was estimated by Wilcoxon signed-ranks test. In 7 of 9 phages. SV mesenchymal cells continued to proliferate in adherent cases, serum MMP-3 level significantly decreased in post-operation, culture and further made cell-type conversion into osteocytes and compared with pre-operation (p<0.05).
  • Chapter 1 Preparedness Against a Pandemic Crisis

    Chapter 1 Preparedness Against a Pandemic Crisis

    The Independent Investigation Commission on the Japanese Government’s Response to COVID-19: Report on Best Practices and Lessons Learned Part III Best practices and challenges Chapter 1 Preparedness against a pandemic crisis What systems do you build up in advance to respond to a crisis in case it happens? Being ready for the onslaught of a crisis is generally called preparedness. Japan’s preparedness in dealing with infectious disease crises has evolved through the nation’s experience of responding to a series of such crises. In this chapter, we examine the state of Japan’s preparedness for managing an infectious disease crisis up to the point just before the outbreak of the novel coronavirus disease by reviewing its history of dealing with such crises. In particular, we focus on laws and organizations as an infrastructure for supporting governance in managing an infectious disease crisis. 1. The history of Japan’s efforts to control infectious disease crises Infectious disease crises have been taking place with increasing frequency around the world since the turn of the century. In Japan, the Health, Labor and Welfare Ministry took charge of building and expanding crisis management systems against infectious diseases each time such a crisis hit somewhere in the world. Among these crises of the 21st century, two – the H1N1 novel influenza pandemic of 2009 and the Ebola virus that hit western Africa in 2014 – have played particularly important roles in prompting the government, mainly the health ministry, to build and enhance Japan’s capacity
  • The 93 CSJ Annual Meeting 2013- Asian International Symposium

    The 93 CSJ Annual Meeting 2013- Asian International Symposium

    Program for Lectures in English -The 93rd CSJ Annual Meeting 2013- Date: from March 22nd (FRI) to March 25th (MON) Venue: Ritsumeikan University, Biwako-kusatsu Campus (Shiga, Japan) ◆ Asian International Symposium 【Physical Chemistry】 March 24th (SUN) 13:00 - 16:50 Room G8 (PRISM HOUSE P114) ………………p.2 【Photo Chemistry】 March 24th (SUN) 10:00 - 17:30 Room A1 (CO-LEARNING HOUSE I C103) …p.2 【Theoretical Chemistry, Chemoinformatics, Computational Chemistry】 ……………………………p.3 March 24th (SUN) 13:30 - 17:10 Room G3 (PRISM HOUSE P109) 【Inorganic Chemistry / Coordination Chemistry, Organo-metallic Chemistry】 ……………………p.3 March 24th (SUN) 13:30 - 17:00 Room B3 (CO-LEARNING HOUSE II 801) 【Organic Chemistry / Green Sustainable Chemistry】 ……………………………………………………p.4 March 24th (SUN) 12:50 - 17:40 Room F6 (FOREST HOUSE F306) 【Natural Products Chemistry, Chemical Biology / Biofunctional Chemistry and Biotechnology】 p.4 March 24th (SUN) 9:30 - 16:20 Room D2 (FOREST HOUSE F109) 【Polymer】 March 24th (SUN) 13:00 - 17:30 Room C6 (FOREST HOUSE F106) ……………p.5 ◆ 3rd CCS-CSJ, Young Chemists Forum ………………………………………………………………p.5 －Effective Utilization of Elements and its Chemical Applications March 24th (SUN) 9:00-17:10 Room S9（CO-LEARNING HOUSE II C601） ◆ 4th RSC-CSJ Joint Symposium 2013 …………………………………………………………………p.6 －Chemical Biology Research by Young Investigators－ March 24th (SUN) 09:10-17:40 Room S8 (CO-LEARNING HOUSE I C306) ◆ Japan-Canada Joint International Symposium on Transition Metal …………………p.7 Catalysts and Synthetic Processes for the Next Generation March
  • City Council Agenda

    City Council Agenda

    CITY of NOVI CITY COUNCIL Agenda Item D July 27, 2015 SUBJECT: Approval and authorization for City Manager to travel September 7 - 16, 2015 with representatives from the City of Southfield, Oakland County and Detroit Regional Chamber to promote the City of Novi to perspective Japanese companies for the not-to-exceed amount of $6,500. SUBMITTING DEPARTMENT: City Manager's CITY MANAGER APPROVAL: ~ EXPENDITURE REQUIRED $6,500 AM OUNT BUDGET ED $0 APPROP RIATION REQ UIRED $6,500 LINE ITEM NUM BE R 101-172.00-956.000 BACKGROU ND INFORMATION: As a continued effort to retain and grow economic development efforts within the City of Novi and the Metro Detroit area, the City Manager has been asked to join representatives from City of Southfield, Oakland County and the Detroit Regional Chamber to travel to Japan. The focus for the City of Novi is to meet with prospective companies to introduce them to the City of Novi and what it has to offer while fostering a relationship for the future. Additionally, several visits have been planned with current Novi firms and potential new companies who are looking to expand their footprint in the United States. The City Manager will be attending the Midwest US-Japan Association Trade Conference in Tokyo from September 13-15. Governor Rick Snyder and Honorable Kazuyuki Katayama, Consul General of Japan in Detroit will be guest speakers. RECOMMENDED ACTI ON: Approval and authorization for City Manager to travel September 7- 16, 2015 with representatives from the City of Southfield, Oakland County and Detroit Regional Chamber to promote the City of Novi to perspective Japanese companies for the not-to-exceed amount of $6,500.
  • Midwest NEWSLETTER Illinois • Indiana • Iowa • Kansas • Michigan • Minnesota • Missouri • Nebraska • North Dakota • Ohio • South Dakota • Wisconsin

    Midwest NEWSLETTER Illinois • Indiana • Iowa • Kansas • Michigan • Minnesota • Missouri • Nebraska • North Dakota • Ohio • South Dakota • Wisconsin

    Vol. 25, No. 4, Autumn, 2015 Japan External Trade Organization 1 East Wacker Drive, Suite 3350 Chicago, IL 60601 Phone: 312-832-6000 Fax: 312-832-6066 Midwest www.jetro.org NEWSLETTER Illinois • Indiana • Iowa • Kansas • Michigan • Minnesota • Missouri • Nebraska • North Dakota • Ohio • South Dakota • Wisconsin In this issue ... The 47th Annual Joint Meeting: • JETRO Around the Midwest ... page 2 “More Relevant Than Ever” The 70th anniversary of the end of • Dukane Corporation finds Success in Japan ... World War II last month was a timely page 3 From the Chief date to confirm the strong ties that • Special Report: 47th Annual Midwest U.S.-Japan now exist between Japan and the Association Conference ... pages 4-6 Executive U.S. Midwest. The 47th Annual Joint Director Meeting of the Japan-Midwest U.S. • METI launches “Nippon Quest” Website ... page 7 Ichiro Soné and Midwest U.S.-Japan Associations Chief Executive Director, was held in Tokyo from September 13- • JETRO Releases Global Trade and Investment 15, and it was a big success. Report 2015 ... page 7 JETRO Chicago The latest meeting followed Prime • Japan Prime Minister Abe Speaks at Invest in Minister Shinzo Abe’s state visit and his address to a joint meeting of the U.S. Congress Japan Seminar in New York City ... page 9 in April and a business mission in June from the Keidanren (The Japan Business Federation). The mission consisted of three groups and brought over 100 CEOs and senior executives to 10 U.S. cities, including Illinois, Indiana and Ohio. JETRO to Host Japan Yoichi Miyazawa, Japan’s Minister of Economy, Trade and Industry (METI), and Caroline Kennedy, U.S.
  • Thermec'2018 Conference Program

    Thermec'2018 Conference Program

    THERMEC’2018 International Conference on PROCESSING & MANUFACTURING OF ADVANCED MATERIALS Processing, Fabrication, Properties, Applications July 9-13, 2018 Paris, FRANCE CONFERENCE PROGRAM IMPORTANT REQUEST TO THERMEC‘2018 PARTICIPANTS THERMEC LUNCHEON GROUP A, B and C & TIMINGS FOR EACH GROUP The dining hall ( au LOFT, where luncheon on Monday, Tuesday, Wednesday & Thursday ) at this venue has maximum sitting capacity of 550 persons. Due to safety reasons, it is important that not more than 550 persons take luncheon at a time. We request your cooperation in this matter. LUNCHEON TIMES FOR GROUPS ARE: GROUP-A (Last Names : A to H ) 12h00 to 12h40 GROUP-B (Last Names : I to P ) 12h40 to 13h20 GROUP-C (Last names : Q to Z ) 13h20 to 14h00 We would appreciate if you please observe above arrangement in order to avoid overcrowding in the dining hall & area THERMEC’2018 INTERNATIONAL CONFERENCE on PROCESSING & MANUFACTURING OF ADVANCED MATERIALS July 09- 13, 2018 Cité des Sciences et de l’industrie, 30 Avenue Corentin Cariou, 75019 Paris, France CONFERENCE PROGRAM Intl’ Conf. on Processing & Manufacturing of Advanced Materials July 9 – 13, 2018, Paris, France Contents General Information ……………………………………………………………………………………….…...1 Acknowledgements …………………………………………………………………………………… ……….6 Inaugural Session ……………………………………………………………………………………. ……….14 Sessions Matrix…………………………………………………………………………………………………15 Session A – Room : Louis Armand Est SESSION A1 : Advanced Steels & TMP Micro-alloyed Steels 1…………………………………………........17 SESSION A2 : Advanced Steels
  • Securities Code 8725 June 4, 2021 Dear Shareholders

    Securities Code 8725 June 4, 2021 Dear Shareholders

    [English Translation] Securities Code 8725 June 4, 2021 Dear Shareholders: Notice of Convocation of the 13th Annual Shareholders Meeting MS&AD Insurance Group Holdings, Inc. (the “Company”) hereby announces that its 13th Annual Shareholders Meeting will be held as set out below. In order to prevent the spread of the new coronavirus disease (COVID-19), we request all shareholders to make their best efforts to exercise their voting rights in advance via the Internet or in writing, and to refrain from attending the Annual Shareholders Meeting regardless of their health. We also ask that you please review the attached Reference Document for Shareholders Meeting before placing your votes. Yours faithfully, MS&AD Insurance Group Holdings, Inc. 27-2, Shinkawa 2-chome, Chuo-ku, Tokyo By: Noriyuki Hara Director, President & CEO Particulars 1. Date and Time: 10:00 a.m., on June 28, 2021 (Monday) (Entry starts at 9:00 a.m.) 2. Place: Mitsui Sumitomo Insurance Surugadai Building 9, Kanda-Surugadai, 3-chome, Chiyoda-ku, Tokyo 3. Purposes of the Meeting: Matters to be reported: 1. Business Report, Consolidated Financial Statements, and a report on the Results of Audit of Consolidated Financial Statements by Accounting Auditors and the Audit & Supervisory Board for the 13th fiscal year (Fiscal 2020 (from April 1, 2020 to March 31, 2021)); and 2. Report on the Non-Consolidated Financial Statements for the 13th fiscal year (Fiscal 2020 (from April 1, 2020 to March 31, 2021)). - 1 - Matters to be resolved: First Proposal: Appropriation of Surplus Second Proposal: Election of Ten (10) Directors Third Proposal: Election of Two (2) Audit & Supervisory Board Members Fourth Proposal: Election of One (1) Substitute Audit & Supervisory Board Member Fifth Proposal: Payment of Condolence Money for the Late Director Kazuhito Ikeo 1.